Simpson Thacher opposed class cert on the grounds that the Pipefitters fund isn't a typical or adequate lead plaintiff. The fund is unsuited for the role, the Pfizer lawyers argued, because it bought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results